Bioactive Coated Medical Device Surface Functionalization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing medical devices coated with bioactive agents often fail to achieve consistent and reliable coatings, leading to variable therapeutic results due to inadequate adhesion and release rates, which do not meet regulatory standards and can cause foreign body reactions.
Innovation Solution
The method involves functionalizing the medical device surfaces with carboxylic acid to increase acidic polar components, allowing for direct application of a bioactive agent layer without containment mechanisms, enhancing adhesion and uniformity of the coating.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If a bioactive agent is applied to an untreated surface of a medical device, then the coating process is simple, but the coating is non-uniform and adhesion is poor
Solution Approach 1:
The medical device surface is subjected to a plasma treatment before coating application. This preliminary action modifies the surface properties to enhance adhesion and uniformity of the subsequent bioactive agent coating, resolving the contradiction between simple coating process and poor coating quality.
Solution Approach 2:
The surface energy and chemistry of the medical device are changed through plasma treatment. This parameter change creates an optimized surface for coating application, improving both uniformity and adhesion without complicating the overall manufacturing process.
2Reliability
If containment mechanisms are used to hold the bioactive material, then the release rate can be controlled, but the device complexity increases and additional substances are introduced
Solution Approach 1:
The patent removes the containment mechanism from the system entirely. Instead of using polymers or matrices to hold the bioactive agent, the invention relies on direct application to the plasma-treated surface, eliminating complexity while maintaining controlled release through surface modification.
Solution Approach 2:
The plasma-treated surface itself provides the functionality of holding and releasing the bioactive agent. The modified surface acts as both the substrate and the containment structure, eliminating the need for separate containment mechanisms and reducing device complexity.
3Productivity
If the bioactive coating is applied directly without surface treatment, then the manufacturing process is simpler, but the adhesion is insufficient and coating is non-uniform
Solution Approach 1:
A plasma treatment step is introduced as a preliminary action before coating application. This prepares the surface to ensure consistent and uniform coating formation, improving manufacturing precision while maintaining productivity through an efficient surface modification process.
Solution Approach 2:
The surface parameters (energy, chemistry, roughness) are modified through plasma treatment to optimize coating application. This creates ideal conditions for uniform adhesion and consistent coating thickness, resolving the contradiction between manufacturing efficiency and coating quality.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in improved bioactive agent retention and consistent, uniform coatings on medical devices, ensuring effective drug release and compliance with regulatory standards without the need for additional containment substances.
Implementation Method 1
functionalizing the at least one surface of the structure by subjecting the at least one surface to acidification by a carboxylic acid to form at least one acid functionalised surface
Data Source
AI summary
A medical device such as a stent or medical balloon is functionalised prior to coating with a bioactive material, specifically by carboxylic acidification of the contact surface or surfaces of the medical device. The preferred process involves washing a stent or other medical device in a washing solution which may be sodium hydroxide, soaking in a carboxylic acid solution, rinsing in water to remove excess carboxylic acid, allowing to dry before applying a bioactive agent layer. It has been found that washing after functionalisation removes excess carboxylic acid and enhances the retention of bioactive agent on the contact surface or surfaces of the medical device leading to a more uniform and consistent layer of bioactive agent.